title: Immunohistochemical and ultrastructural analysis of dysplastic epithelium of human ocular surface: basement membrane and intermediate filament.
abstract: OBJECTIVE
  The dysplastic corneal epithelium is characterized by the abnormal proliferation of epithelial cells. The phenotypes of these cells have not been elucidated. We investigated whether such epithelium expresses the phenotypes of corneal or conjunctival epithelial cells.
  
  
  METHODS
  The corneas and conjunctivae from four normal subjects and from one patient with epithelial dysplasia of the central cornea were immunostained for IV and VII collagens and for cytokeratins. Monoclonal antibodies against collagen IV reacted to the [alpha1(IV)]2alpha2(IV) or alpha5(IV) molecule. Anti-cytokeratin antibodies were used to define epithelial cell types. The ultrastructure of the basement membrane (BM) of each specimen also was examined.
  
  
  RESULTS
  Type VII collagen immunoreactivity was detected in all the specimens of epithelial BM. The anti-collagen IV [alpha1(IV)]2alpha2(IV) antibody labeled the conjunctival BMs, not the BMs of the corneal epithelia, of each subject. The normal corneal epithelial BM, not the BM of the conjunctival or dysplastic corneal epithelium, was immunolabeled with anti-alpha5(IV) antibody. The pattern of cytokeratin expression in the corneal epithelial dysplasia resembled that seen in the normal conjunctivae. Small breaks in the BM of dysplastic corneal epithelium were ultrastructurally revealed. The number of hemidesmosomes in the dysplastic corneal epithelium was decreased as compared with that in the normal BM.
  
  
  CONCLUSIONS
  The composition of collagen types within the BM and the cellular phenotype of the dysplastic epithelium in the cornea resembled those of conjunctival epithelium, not of the cornea.
authors.affiliation: Department of Ophthalmology, University of Cincinnati Medical Center, Ohio 45267-0527, USA.
authors.forename: S
authors.initials: S
authors.lastname: Saika
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
authors.forename: Y
authors.initials: Y
authors.lastname: Okada
authors.forename: K
authors.initials: K
authors.lastname: Ohkawa
authors.forename: O
authors.initials: O
authors.lastname: Yamanaka
authors.forename: T
authors.initials: T
authors.lastname: Katoh
authors.forename: Y
authors.initials: Y
authors.lastname: Ohnishi
authors.forename: A
authors.initials: A
authors.lastname: Ooshima
authors.forename: W W
authors.initials: WW
authors.lastname: Kao
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal; D001485:Basement Membrane / Q000378:metabolism / Q000648:ultrastructure; D002278:Carcinoma in Situ / Q000378:metabolism* / Q000648:ultrastructure; D003094:Collagen / Q000378:metabolism* / Q000648:ultrastructure; D003228:Conjunctiva / Q000378:metabolism / Q000648:ultrastructure; D003316:Corneal Diseases / Q000378:metabolism* / Q000473:pathology; D019573:Epithelium, Corneal / Q000378:metabolism* / Q000648:ultrastructure; D005109:Extracellular Matrix / Q000378:metabolism / Q000648:ultrastructure; D005134:Eye Neoplasms / Q000378:metabolism* / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007633:Keratins / Q000378:metabolism* / Q000648:ultrastructure; D007797:Laminin / Q000378:metabolism / Q000648:ultrastructure; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D007797:Laminin; D007633:Keratins; D003094:Collagen